Paper19716622
Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.
Kitamura H and 4 others. Lung Cancer, 2009. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer. Papers, record 19716622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19716622
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Neoplastic Stem Cells | Major topic |
| Small Cell Lung Carcinoma | Major topic |
| Animals | |
| Antigens, Differentiation | |
| Diagnosis, Differential | |
| Humans | |
| Signal Transduction | |
| Stem Cell Niche |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40862704 | From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune-Inflammatory Landscape Underlying Lung Cancer Distant Spreading-A Narrative Review. | Cells | 2025 | https://conductscience.org/library/papers/40862704 | PubMed |
| 39519311 | Role of Peroxisome Proliferator-Activated Receptor α-Dependent Mitochondrial Metabolism in Ovarian Cancer Stem Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519311 | PubMed |
| 39301386 | CD10 Immunohistochemical Expression in Breast Carcinoma and Its Correlation With Clinicopathological Parameters. | Cureus | 2024 | https://conductscience.org/library/papers/39301386 | PubMed |
| 39091989 | Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression. | Oncol Rev | 2024 | https://conductscience.org/library/papers/39091989 | PubMed |
| 38481252 | Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis. | J Ovarian Res | 2024 | https://conductscience.org/library/papers/38481252 | PubMed |
| 37421554 | Application of three-dimensional cell culture technology in screening anticancer drugs. | Biotechnol Lett | 2023 | https://conductscience.org/library/papers/37421554 | PubMed |
| 36615496 | Chemistry and Biological Activities of Naturally Occurring and Structurally Modified Podophyllotoxins. | Molecules | 2022 | https://conductscience.org/library/papers/36615496 | PubMed |
| 35207472 | Identification, Culture and Targeting of Cancer Stem Cells. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35207472 | PubMed |
| 34715859 | LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34715859 | PubMed |
| 34441397 | ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34441397 | PubMed |
| 33095384 | Cancer stem cells and strategies for targeted drug delivery. | Drug Deliv Transl Res | 2021 | https://conductscience.org/library/papers/33095384 | PubMed |
| 31810474 | Ovarian cancer stem cells and targeted therapy. | J Ovarian Res | 2019 | https://conductscience.org/library/papers/31810474 | PubMed |
| 31121479 | miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling. | Mol Ther Nucleic Acids | 2019 | https://conductscience.org/library/papers/31121479 | PubMed |
| 31001473 | Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From Gprc5a-Deficient Murine Lung Adenocarcinoma With Somatic Kras Mutations. | Front Oncol | 2019 | https://conductscience.org/library/papers/31001473 | PubMed |
| 30941305 | Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach. | Front Oncol | 2019 | https://conductscience.org/library/papers/30941305 | PubMed |
| 30416780 | A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification. | J Thorac Dis | 2018 | https://conductscience.org/library/papers/30416780 | PubMed |
| 30211124 | Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. | Front Oncol | 2018 | https://conductscience.org/library/papers/30211124 | PubMed |
| 29306324 | Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29306324 | PubMed |
| 29285189 | Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29285189 | PubMed |
| 28811688 | Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population. | Indian J Clin Biochem | 2017 | https://conductscience.org/library/papers/28811688 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19716622
GET https://conductscience.org/api/papers/v1/19716622/cited_by?page=2